224 related articles for article (PubMed ID: 31727237)
21. The P2X7 receptor: A main player in inflammation.
Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
[TBL] [Abstract][Full Text] [Related]
22. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
[TBL] [Abstract][Full Text] [Related]
23. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
[TBL] [Abstract][Full Text] [Related]
24. P2X7 receptor large pore signaling in avian Müller glial cells.
Faria RX; Freitas HR; Reis RAM
J Bioenerg Biomembr; 2017 Jun; 49(3):215-229. PubMed ID: 28573491
[TBL] [Abstract][Full Text] [Related]
25. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
26. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage.
Safya H; Mellouk A; Legrand J; Le Gall SM; Benbijja M; Kanellopoulos-Langevin C; Kanellopoulos JM; Bobé P
Front Immunol; 2018; 9():360. PubMed ID: 29535730
[TBL] [Abstract][Full Text] [Related]
27. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket.
Bin Dayel A; Evans RJ; Schmid R
Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019
[TBL] [Abstract][Full Text] [Related]
28. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
29. The P2X7 Receptor in Infection and Inflammation.
Di Virgilio F; Dal Ben D; Sarti AC; Giuliani AL; Falzoni S
Immunity; 2017 Jul; 47(1):15-31. PubMed ID: 28723547
[TBL] [Abstract][Full Text] [Related]
30. P2X7R large pore is partially blocked by pore forming proteins antagonists in astrocytes.
Faria RX; Reis RA; Ferreira LG; Cezar-de-Mello PF; Moraes MO
J Bioenerg Biomembr; 2016 Jun; 48(3):309-24. PubMed ID: 26830892
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
[TBL] [Abstract][Full Text] [Related]
32. The P2X7 receptor: shifting from a low- to a high-conductance channel - an enigmatic phenomenon?
Alves LA; de Melo Reis RA; de Souza CA; de Freitas MS; Teixeira PC; Neto Moreira Ferreira D; Xavier RF
Biochim Biophys Acta; 2014 Oct; 1838(10):2578-87. PubMed ID: 24857862
[TBL] [Abstract][Full Text] [Related]
33. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
[TBL] [Abstract][Full Text] [Related]
34. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
35. Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells.
Pislyagin E; Kozlovskiy S; Menchinskaya E; Chingizova E; Likhatskaya G; Gorpenchenko T; Sabutski Y; Polonik S; Aminin D
Bioorg Med Chem; 2021 Feb; 31():115975. PubMed ID: 33401207
[TBL] [Abstract][Full Text] [Related]
36. Purinergic receptors: new targets for the treatment of gout and fibrosis.
Gicquel T; Le Daré B; Boichot E; Lagente V
Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
[TBL] [Abstract][Full Text] [Related]
37. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
[TBL] [Abstract][Full Text] [Related]
38. The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy.
Tassetto M; Scialdone A; Solini A; Di Virgilio F
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281162
[TBL] [Abstract][Full Text] [Related]
39. Calcium-dependent block of P2X7 receptor channel function is allosteric.
Yan Z; Khadra A; Sherman A; Stojilkovic SS
J Gen Physiol; 2011 Oct; 138(4):437-52. PubMed ID: 21911484
[TBL] [Abstract][Full Text] [Related]
40. Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220+ double-negative T lymphocytes of autoimmune MRL/lpr mice.
Le Gall SM; Legrand J; Benbijja M; Safya H; Benihoud K; Kanellopoulos JM; Bobé P
PLoS One; 2012; 7(12):e52161. PubMed ID: 23284917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
